key: cord-1045018-0yfrwal6
authors: Timek, Tomasz A.
title: Commentary: Whether it's the best of times or the worst of times, it's the only time we've got
date: 2020-12-29
journal: JTCVS open
DOI: 10.1016/j.xjon.2020.12.007
sha: 73e7411d5cba5931dadf339ad48b923bd9acedca
doc_id: 1045018
cord_uid: 0yfrwal6

nan

Commentary: Whether it's the best of times or the worst of times, it's the only time we've got Q1 Q5 Tomasz A. Timek, MD, PhD

The COVID-19 pandemic has upended life as we know it worldwide in 2020 and has especially challenged health care systems in affected countries. Our specialty of cardiothoracic surgery has not been spared from the wave of ill patients overwhelming hospital wards and intensive care units. However, limited access to treatment of cardiothoracic patients may have dire consequences owing to the potentially high morbidity and mortality of untreated cardiac or pulmonary pathology. The cardiac surgical community has responded with a well-coordinated response defining the early triage procedures in centers most affected in the early stages of the pandemic 1 and rapid reporting of the North American 2 and international 3 experience for guidance. Our European colleagues have likewise "circled the wagons" to provide early descriptions of treatment algorithms from Italy and reporting of national data. In this issue of the Journal, Lopez-Marco and colleagues 5 present a multicenter United Kingdom experience on treatment pathways and outcomes of patients with acute aortic syndromes during the first phase of the pandemic. The authors report maintained access to emergent aortic procedures and similar outcomes as in the prepandemic period. Seven patients in the series were diagnosed with COVID-19, although no deaths were attributable to the infection.

A recent study from 2 Chinese centers and the University of Michigan suggested that patients with COVID-19 infection and type A aortic dissection may be at higher risk of mortality, whereas intervention in patients recovered from recent infection may be safe. 6 Two smaller Chinese reports 7,8 during the first phase of the pandemic demonstrated equivalent results to pre-pandemic data, yet in one of the studies, all patients ultimately tested negative for the virus. How COVID-19 status and timing of infection factors into perioperative outcomes of acute aortic syndromes remains unclear, but the lethal nature of this surgical pathology makes the decision making process less complicated, as most centers would not deny surgical intervention based on COVID-19 status. In more elective cardiac surgery cases, the treatment algorithm becomes more troublesome. Fattouch and colleagues 9 reported 15% mortality in cardiac surgery patients who develop COVID-19 during their hospital course, emphasizing the higher-than-expected death rate based on preoperative clinical risk factors. On the other hand, limiting the access of cardiac surgical patients to operative intervention may have significant untoward effects. 10 Lopez-Marco and colleagues provide organizational guidance for treating patients with aortic syndromes in a national health care system during the height of the pandemic, and they should be congratulated on their efforts to maintain clinical access. However, these efforts represent more administrative and organization strategies rather than clinical decision making. The risk-benefit ratio for cardiac surgical patients with less lethal pathologies remains to be clearly defined, as does the influence of the timing of infection on the timing of surgery .  127  128  129  130  131  132  133  134  135  136  137  138  139  140  141  142  143  144  145  146  147  148  149  150  151  152  153  154  155  156  157  158  159  160  161  162  163  164  165  166  167  168  169  170  171  172  173  174  175  176  177  178  179  180  181  182  183  184  185  186  187 

The rapid transformation of cardiac surgery practice in the coronavirus disease 2019 (COVID-19) pandemic: insights and clinical strategies from a center at the epicenter

COVID-19 North American Cardiac Surgery Survey Working Group. Cardiac surgery in North America and coronavirus disease 2019 (COVID-19): regional variability in burden and impact. J Thorac Cardiovasc Surg

Response of cardiac surgery units to COVID-19: an internationally based quantitative survey

Italian Society for Cardiac Surgery Task Force on COVID-19 Pandemic. The COVID-19 outbreak and its impact on hospitals in Italy: the model of cardiac surgery

The fate of patients with acute aortic syndromes during the COVID-19 pandemic: a UK multicenter study

Type A aortic dissection during the COVID-19 pandemic: report from tertiary aortic centers in the United States and China. Q4 Semin Thorac Cardiovasc Surg

Early outcomes of Stanford type A aortic dissection under the coronavirus disease 2019 (COVID-19) pandemic: a multicentre study from Hubei province

Management of acute type A aortic dissection during COVID-19 outbreak: the Anzhen experience

Cardiac surgery outcomes in patients with coronavirus disease 2019 (COVID-19): a case-series report

Assessing the collateral damage of the novel coronavirus: a call to action for the post-COVID-19 Era

Impact of septal myectomy volume on mitral valve replacement rate in hypertrophic cardiomyopathy patients